about
FGF23 and Phosphate Wasting DisordersA unified model for bone-renal mineral and energy metabolismTumour-induced osteomalacia: a literature review and a case reportRenal control of calcium, phosphate, and magnesium homeostasisHigh bone mineral apparent density in children with X-linked hypophosphatemia.Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysisPrimary hypoparathyroidism presenting with heart failure and ventricular fibrillation.Mineral (Mal)Adaptation to Kidney Disease--Young Investigator Award Address: American Society of Nephrology Kidney Week 2014Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications.Fibroblast growth factor 23 and bone mineralisation.Treatment of Hypophosphatemic Rickets with Phosphate and Active Vitamin D in Japan: A Questionnaire-based Survey.Na+-independent phosphate transport in Caco2BBE cells.Successful Medical Therapy for Hypophosphatemic Rickets due to Mitochondrial Complex I Deficiency Induced de Toni-Debré-Fanconi Syndrome.Increased osteopontin contributes to inhibition of bone mineralization in FGF23-deficient mice.Adult-onset hypophosphatemic osteomalacia associated with Sjogren syndrome: Clinical case reportHypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review.Hypophosphatemic rickets: unraveling the role of FGF23.FGF23 associated bone diseases.Developmental defects of enamel and dentine: challenges for basic science research and clinical management.Intestinal phosphate transport: a therapeutic target in chronic kidney disease and beyond?Inherited disorders of calcium and phosphate metabolism.Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones.Review of the dental implications of X-linked hypophosphataemic rickets (XLHR).Tumor-Induced Osteomalacia: an Up-to-Date Review.Phosphate enhances Fgf23 expression through reactive oxygen species in UMR-106 cells.Oncogenic osteomalacia illustrating the effect of fibroblast growth factor 23 on phosphate homeostasis.Osteomalacia and Fanconi's syndrome caused by long-term low-dose adefovir dipivoxil.Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin.A case report of phosphaturic mesenchymal tumor-induced osteomalacia.Defective Mineralization in X-Linked Hypophosphatemia Dental Pulp Cell Cultures.FGF23 Is Not Required to Regulate Fetal Phosphorus Metabolism but Exerts Effects Within 12 Hours After Birth.Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets.Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification.Acquired hypophosphatemic osteomalacia is easily misdiagnosed or neglected by rheumatologists: A report of 9 cases.Magnetic Resonance Imaging Features as Surrogate Markers of X-Linked Hypophosphatemic Rickets Activity
P2860
Q26851904-1F5D8019-CBDD-42E0-8E24-E573D7A23E1BQ27690863-A409B1C0-BCBA-4E1C-B8D2-C832A26A7BD6Q28069314-D1E6196C-86D2-424D-81D4-AF388683A232Q34442093-114AD2FF-377B-42C3-9568-C4C647FCB88BQ34579718-44C95D4E-52A6-4809-B6B5-1D1578500F69Q35067500-5086AB44-C594-467F-B3EB-DEEEFF397424Q35140676-AF622FCD-BD63-497F-8A27-7FB0F745D5F8Q35444089-15255FCE-D508-4484-A7A9-5A1DA68159C2Q36123640-D66EDA15-0E50-4635-BD2D-98CA7140DE13Q36360389-942AE0B3-AB77-4FAF-AE91-273E070097F7Q36756061-D7778A6A-8F48-4D62-8827-6D84A1D57459Q37107383-58CE59F3-4043-482E-8735-B2E7CCE8D1FDQ37148778-F6373967-73A6-4601-8E50-F36926E73658Q37413220-B9325152-A589-41B8-8785-2C80FA570E1CQ37607946-211E3C7F-FBD0-44CE-8E52-78BEA04DCEEFQ37737303-0F6061A2-E41B-40F9-AB7C-10A0E447E2F4Q38043348-785044D4-6BC3-4C4C-964B-2FBF3D2C5E31Q38045788-1FC40464-C37A-4BC7-B0F7-3C7481752D55Q38087548-F6267D2C-DB7F-4AAB-B2CC-9B6959B90AABQ38155909-C6BC887A-A826-4C4E-A014-F2ECE7238D09Q38185277-09797E3F-30C3-4C64-AB80-BEEEA77514F1Q38189644-AE1F88EF-841A-4EC9-AB39-4739359289DEQ38257346-518A44D5-5502-43AD-B7FD-E9EE296691ABQ38353842-E19FAFE5-85C1-4995-99EC-79AAB39EF533Q38434288-A059023B-55C7-4D1E-9CA9-1C8338BEC069Q38897244-3BBE8E57-BC6E-4217-8BBB-C5809EAE35C3Q39720272-2D8914E4-CED5-4949-9B34-64ABA5740CC6Q41461791-643A45CF-84D1-4663-8306-0ECCD68C9FDDQ42869686-7195BA3D-FE2E-459A-A44B-06ECC6BF62A0Q47640215-A8A0A121-BB57-42A8-BEEB-7A791D09FB18Q47842811-A9C292AF-4B89-4D62-BFB5-87464093D432Q49873034-0E36C89F-A3DB-43CF-8728-C74F60007CA4Q54305276-77E824A2-2620-447B-A85D-3BC66E60C0CEQ54456673-57124F95-C153-4727-8CAC-A68F9CC7E8D5Q55297521-18E68E00-C1CA-426B-AAD3-80CB94C53366Q57736114-30E69781-9819-4F2F-9AE9-B3465D93BCB2
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The expanding family of hypophosphatemic syndromes.
@en
The expanding family of hypophosphatemic syndromes.
@nl
type
label
The expanding family of hypophosphatemic syndromes.
@en
The expanding family of hypophosphatemic syndromes.
@nl
prefLabel
The expanding family of hypophosphatemic syndromes.
@en
The expanding family of hypophosphatemic syndromes.
@nl
P2860
P1476
The expanding family of hypophosphatemic syndromes.
@en
P2093
Thomas O Carpenter
P2860
P2888
P356
10.1007/S00774-011-0340-2
P577
2011-12-14T00:00:00Z